174 related articles for article (PubMed ID: 24326769)
1. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
Hu S; Zhao L; Yang J; Hu M
Tumour Biol; 2014 Apr; 35(4):3647-56. PubMed ID: 24326769
[TBL] [Abstract][Full Text] [Related]
2. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.
Hu S; Zhao L; Yang J; Hu M
Meta Gene; 2013 Dec; 1():126-37. PubMed ID: 25606382
[TBL] [Abstract][Full Text] [Related]
3. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
Lv L; Wang P; Zhou X; Sun B
Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
5. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.
Chen X; Liu F; Li B; Wei YG; Yan LN; Wen TF
World J Gastroenterol; 2011 Mar; 17(9):1211-8. PubMed ID: 21448428
[TBL] [Abstract][Full Text] [Related]
7. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
8. The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population.
Hu M; Zhao L; Hu S; Yang J
PLoS One; 2013; 8(2):e57012. PubMed ID: 23437296
[TBL] [Abstract][Full Text] [Related]
9. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
10. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis.
Sahu SK; Chakrabarti S; Roy SD; Baishya N; Reddy RR; Suklabaidya S; Kumar A; Mohanty S; Maji S; Suryanwanshi A; Rajasubramaniam S; Asthana M; Panda AK; Singh SP; Ganguly S; Shaw OP; Bichhwalia AK; Sahoo PK; Chattopadhyay NR; Chatterjee K; Kundu CN; Das AK; Kannan R; Zorenpuii ; Zomawia E; Sema SA; Singh YI; Ghosh SK; Sharma K; Das BS; Choudhuri T
Oncogenesis; 2016 May; 5(5):e225. PubMed ID: 27159678
[TBL] [Abstract][Full Text] [Related]
12. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
13. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis.
Jia S; Tang W; Luo Y
Hepatol Int; 2013 Jun; 7(2):669-75. PubMed ID: 26201800
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis.
Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK
PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975
[TBL] [Abstract][Full Text] [Related]
17. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
Duan X; Li J
Medicine (Baltimore); 2017 Sep; 96(36):e7856. PubMed ID: 28885338
[TBL] [Abstract][Full Text] [Related]
18. [Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Zhu GS; Liu SF; Xian ZH; Wu WQ; Zhang XZ; Wang YH; Wu MC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):632-5. PubMed ID: 16331559
[TBL] [Abstract][Full Text] [Related]
19. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
Jiang N; Pan J; Wang L; Duan YZ
Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
[TBL] [Abstract][Full Text] [Related]
20. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
